RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$15.22
Tradestie Score
53
Market Cap
$2.89B
Revenue Growth
0.3%
Analyst Upside
+84.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.21
|
$1.55B | - | 63 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.64
|
$1.55B | 12.7 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.19
|
$1.55B | - | 54 | Compare |
|
NVAX
Novavax Inc
|
$10.46
|
$1.54B | - | 41 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.83
|
$1.50B | 7.0 | 49 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$27.67
|
$1.50B | - | 40 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$27.79
|
$1.49B | - | 54 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.44
|
$1.43B | - | 66 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.93
|
$1.42B | - | 73 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$17.60
|
$1.35B | - | 70 | Compare |
More RARE Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry